Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Macrophage imaging within human cerebral aneurysms wall using ferumoxytol-enhanced MRI: a pilot study.

Hasan DM, Mahaney KB, Magnotta VA, Kung DK, Lawton MT, Hashimoto T, Winn HR, Saloner D, Martin A, Gahramanov S, Dósa E, Neuwelt E, Young WL.

Arterioscler Thromb Vasc Biol. 2012 Apr;32(4):1032-8. doi: 10.1161/ATVBAHA.111.239871. Epub 2012 Feb 9.

2.

Imaging aspirin effect on macrophages in the wall of human cerebral aneurysms using ferumoxytol-enhanced MRI: preliminary results.

Hasan DM, Chalouhi N, Jabbour P, Magnotta VA, Kung DK, Young WL.

J Neuroradiol. 2013 Jul;40(3):187-91. doi: 10.1016/j.neurad.2012.09.002. Epub 2013 Feb 18.

3.

Early change in ferumoxytol-enhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm: a pilot study.

Hasan D, Chalouhi N, Jabbour P, Dumont AS, Kung DK, Magnotta VA, Young WL, Hashimoto T, Winn HR, Heistad D.

Stroke. 2012 Dec;43(12):3258-65. doi: 10.1161/STROKEAHA.112.673400. Epub 2012 Nov 8.

4.

Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysms: preliminary results.

Hasan DM, Chalouhi N, Jabbour P, Dumont AS, Kung DK, Magnotta VA, Young WL, Hashimoto T, Richard Winn H, Heistad D.

J Am Heart Assoc. 2013 Feb 22;2(1):e000019. doi: 10.1161/JAHA.112.000019.

5.

Monitoring the effects of dexamethasone treatment by MRI using in vivo iron oxide nanoparticle-labeled macrophages.

Gramoun A, Crowe LA, Maurizi L, Wirth W, Tobalem F, Grosdemange K, Coullerez G, Eckstein F, Koenders MI, Van den Berg WB, Hofmann H, Vallée JP.

Arthritis Res Ther. 2014 Jun 23;16(3):R131. doi: 10.1186/ar4588.

6.

Ferumoxytol-enhanced MRI to Image Inflammation within Human Brain Arteriovenous Malformations: A Pilot Investigation.

Hasan DM, Amans M, Tihan T, Hess C, Guo Y, Cha S, Su H, Martin AJ, Lawton MT, Neuwelt EA, Saloner DA, Young WL.

Transl Stroke Res. 2012 Jul;3(Suppl 1):166-73. doi: 10.1007/s12975-012-0172-y.

7.

Quantifying Intracranial Aneurysm Wall Permeability for Risk Assessment Using Dynamic Contrast-Enhanced MRI: A Pilot Study.

Vakil P, Ansari SA, Cantrell CG, Eddleman CS, Dehkordi FH, Vranic J, Hurley MC, Batjer HH, Bendok BR, Carroll TJ.

AJNR Am J Neuroradiol. 2015 May;36(5):953-9. doi: 10.3174/ajnr.A4225. Epub 2015 Feb 5.

8.

In vivo imaging of the aneurysm wall with MRI and a macrophage-specific contrast agent.

Truijers M, Fütterer JJ, Takahashi S, Heesakkers RA, Blankensteijn JD, Barentsz JO.

AJR Am J Roentgenol. 2009 Nov;193(5):W437-41. doi: 10.2214/AJR.09.2619.

PMID:
19843724
9.

Pathological findings of saccular cerebral aneurysms-impact of subintimal fibrin deposition on aneurysm rupture.

Hokari M, Nakayama N, Nishihara H, Houkin K.

Neurosurg Rev. 2015 Jul;38(3):531-40; discussion 540. doi: 10.1007/s10143-015-0628-0. Epub 2015 Apr 11.

PMID:
25860660
10.

Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms: preliminary results.

Hasan D, Chalouhi N, Jabbour P, Hashimoto T.

J Neuroinflammation. 2012 Sep 21;9:222. doi: 10.1186/1742-2094-9-222.

11.

Ferumoxytol administration does not alter infarct volume or the inflammatory response to stroke in mice.

Doyle KP, Quach LN, Arceuil HE, Buckwalter MS.

Neurosci Lett. 2015 Jan 1;584:236-40. doi: 10.1016/j.neulet.2014.10.041. Epub 2014 Nov 1.

12.

Feasibility of islet magnetic resonance imaging using ferumoxytol in intraportal islet transplantation.

Jin SM, Oh SH, Oh BJ, Shim W, Choi JM, Yoo D, Hwang YH, Lee JH, Lee DY, Kim JH.

Biomaterials. 2015 Jun;52:272-80. doi: 10.1016/j.biomaterials.2015.02.055. Epub 2015 Feb 28.

PMID:
25818433
13.

Visualization of the aneurysm wall: a 7.0-tesla magnetic resonance imaging study.

Kleinloog R, Korkmaz E, Zwanenburg JJ, Kuijf HJ, Visser F, Blankena R, Post JA, Ruigrok YM, Luijten PR, Regli L, Rinkel GJ, Verweij BH.

Neurosurgery. 2014 Dec;75(6):614-22; discussion 622. doi: 10.1227/NEU.0000000000000559.

PMID:
25255252
14.

Bioluminescence and magnetic resonance imaging of macrophage homing to experimental abdominal aortic aneurysms.

Miyama N, Dua MM, Schultz GM, Kosuge H, Terashima M, Pisani LJ, Dalman RL, McConnell MV.

Mol Imaging. 2012 Apr;11(2):126-34.

PMID:
22469240
15.

Imaging behavior of the normal adrenal on ferumoxytol-enhanced MRI: preliminary findings.

Gunn AJ, Seethamraju RT, Hedgire S, Elmi A, Daniels GH, Harisinghani MG.

AJR Am J Roentgenol. 2013 Jul;201(1):117-21. doi: 10.2214/AJR.12.9357.

PMID:
23789664
16.

Inflammation and intracranial aneurysms.

Chyatte D, Bruno G, Desai S, Todor DR.

Neurosurgery. 1999 Nov;45(5):1137-46; discussion 1146-7.

PMID:
10549930
17.

Molecular imaging of cerebrovascular lesions.

Chalouhi N, Jabbour P, Magnotta V, Hasan D.

Transl Stroke Res. 2014 Apr;5(2):260-8. doi: 10.1007/s12975-013-0291-0. Epub 2013 Oct 23. Review.

PMID:
24323714
18.

Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging.

Hamilton BE, Nesbit GM, Dosa E, Gahramanov S, Rooney B, Nesbit EG, Raines J, Neuwelt EA.

AJR Am J Roentgenol. 2011 Oct;197(4):981-8. doi: 10.2214/AJR.10.5992.

19.

Upregulation of HMGB1 in wall of ruptured and unruptured human cerebral aneurysms: preliminary results.

Zhang D, Wu W, Yan H, Jiang T, Liu M, Yu Z, Li H, Hang C.

Neurol Sci. 2016 Feb;37(2):219-26. doi: 10.1007/s10072-015-2391-y. Epub 2015 Oct 14.

PMID:
26466586
20.

Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism--preliminary experience.

Li W, Salanitri J, Tutton S, Dunkle EE, Schneider JR, Caprini JA, Pierchala LN, Jacobs PM, Edelman RR.

Radiology. 2007 Mar;242(3):873-81.

PMID:
17325072

Supplemental Content

Support Center